Fidelity Investments
EIDX

Fidelity Investments’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Fidelity Investments’s Portfolio EIDX Stock Details EIDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-118,947
Closed -$6.01M – 4463
2020
Q3 		$6.01M Hold
118,947
– – ﹤0.01% 2006
2020
Q2 		$5.67M Sell
118,947
-283,800
-70% -$13.2M ﹤0.01% 2011
2020
Q1 		$19.7M Sell
402,747
-8,500
-2% -$433K ﹤0.01% 1404
2019
Q4 		$23.6M Buy
411,247
+40,000
+11% +$1.98M ﹤0.01% 1533
2019
Q3 		$13.4M Buy
371,247
+206,410
+125% +$8.06M ﹤0.01% 1728
2019
Q2 		$5.12M Buy
+164,837
New +$4.47M ﹤0.01% 2081

Other funds holding EIDX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return